Overview

Fast & Fed Pharmacokinetic (PK) Study

Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide information on how well an extended release formulation (a medication that is released and absorbed over a longer period of time than a regular release formulation of the medication) of naproxen sodium is absorbed into the bloodstream after eating a high calorie breakfast and also after fasting (not eating for 14 hours).
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
Treatments:
Naproxen